We are happy to announce that one of our most recent projects will be financed by the directive of the Free State of Thuringia on the Promotion of Research, Technology and Innovation (FTI, Project. 2024 VFE 0047).

The aim of the project is the development of a vascularized liver-on-chip model with unique features that will allow to investigate personalized responses of pharmacologically active compounds. With this approach, we aim to open novel therapeutic avenues for more effective treatments with less side effects.